Evidence map›Paper›PMID 33689237›Full record

ArticleMolecular genetics & genomic medicine2021

First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.

Inger Norlyk Sheyanth, Ihab Bishara Lolas, Henrik Okkels, Ligor Pradeep Kiruparajan, Søren Kromann Abildgaard, Michael Bjørn Petersen

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Sex Distributions in Non-ABCA4 Autosomal Macular Dystrophies.Investigative ophthalmology & visual science · 2024
    Article
  2. Review
  3. Early-onset drusen in Malattia Leventinese withRomanian journal of ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Inger Norlyk SheyanthResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-5408-8701
Ihab Bishara LolasResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
Henrik OkkelsResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
Ligor Pradeep KiruparajanResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
Søren Kromann AbildgaardResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.
Michael Bjørn PetersenResearch and Knowledge Center in Sensory Genetics, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0003-0316-8207
Aalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDoyne honeycomb retinal dystrophy (DHRD)/malattia leventinese (ML) is an autosomal dominant, progressive retinal disorder characterized by massive central retinal drusen often partly coalescent forming a characteristic honeycomb-like pattern. Debut of vision loss often occurs in early to mid-adulthood, and the degree varies. A single variant in EFEMP1: c.1033C>T (R345W) has been identified as the cause in all cases.

methodsFollowing DNA isolation, exome sequencing was performed in seven genes associated with flecked retina. Direct sequencing was used for variant verification.

resultsWe report the first Scandinavian case of molecular genetically verified DHRD/ML: a 57-year-old woman debuting with vision loss and metamorphopsia. On both eyes, ophthalmological findings included massive hard drusen in the macular region and nasal to the optic disc as well as macular hyperpigmentation. Secondary choroidal neovascularizations were identified on both eyes, and anti-vascular endothelial growth factor was administered, without effect.

conclusionMolecular genetic investigation revealed heterozygosity for the known pathogenic missense variant in EFEMP1: c.1033C>T (R345W) previously reported in relation to DHRD/ML. Family history revealed no other cases of similar visual impairment suggesting a de novo mutation. Furthermore, there was no correlation between the unique DHRD/ML haplotypes reported in the literature and our patient.

Indexed as

Extracellular Matrix ProteinsFemaleHumansMiddle AgedMutation, MissenseOptic Disk DrusenRetinaScandinavian and Nordic CountriesEFEMP1 protein, humanExtracellular Matrix ProteinsDoyne honeycomb retinal dystrophyEFEMP1Malattia leventinese

Identifiers

PMID33689237
PMCPMC8123724
OpenAlexW3134017243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.